Top Markets
Coin of the day
Advanced Health Intelligence Ltd Advanced Health Intelligence Ltd

Advanced Health Intelligence Ltd

AHI
Clasificación en acciones #30279
Advanced Health Intelligence Ltd is an Australian company with global... Advanced Health Intelligence Ltd is an Australian company with global operations, specializing in the creation of mobile applications and technological platforms. The firm owns and patents BodyScan, its unique measurement technology that empowers users to assess their body dimensions using a smartphone. Additionally, it provides FaceScan, which is engineered for measuring vital signs and evaluating the risks associated with cardiovascular disease, heart attacks, and strokes, as well as DermaScan, a specialized dermatological scanning device. Its diverse clientele spans the mobile health and telehealth sectors, life and health insurance providers, the fitness and wellness industry, and consumer apparel companies. Formerly known as MyFiziq Limited, the company adopted the name Advanced Human Imaging Limited in March 2021. Established in 2014, its headquarters are located in South Perth, Australia.
Precio por acción
$0.0648862
Última sincronización: 2024-07-24
Capitalización bursátil
$17.48M
Cambio (1 día)
8.59%
Cambio (1 año)
0.00%
País
AU
Comercio Advanced Health Intelligence Ltd (AHI)

Categoría

Ganancias de Advanced Health Intelligence Ltd (AHI)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Advanced Health Intelligence Ltd, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Advanced Health Intelligence Ltd desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
- -
DE
- -
CA
$10.27B -
US
$6.62B -
US
$2.35B -
US